COVID and DIDs

Hello DIDlandia compatriots,

In behalf of my co-authors at Vrije University and RIVM (National 
Institute for Public Health and the Environment in The Netherlands), I 
am happy to announce the publication of our paper 
/"Blockchain-facilitated sharing to advance outbreak R&D"/ in /Science/ 
Magazine today. The paper offers a unique perspective on the potential 
impact of blockchain technologies to enable more dynamic R&D 
collaboration and innovation in the life sciences. I believe this is the 
first ever mention of decentralized identifiers and verifiable 
credentials in this eminent journal. For those interested, the full 
paper can be found here:

    *https://science.sciencemag.org/content/368/6492/719*

I've asked the first author Mark van der Waal to attend a CCG call in 
the near future to answer any questions you may have directly, discuss 
your perspectives on the optimal implementation of DIDs and VCs, and to 
explore possibilities for partnership.

Also, a nod to Kim Hamllton Duffy who was very helpful to the authors, 
and was acknowledged in the paper for her contribution.

FYI, the paper proposes that outbreak R&D records could be stored in a 
repository allowing related records to be linked, with data structuring 
to capture the evolution of R&D branches over time, in a manner similar 
to GitHub. I believe that the resulting direct acyclic graphs could 
assist in consolidating IPRs over collaborative inventions with smart 
contracts that define how to equitably distribute ownership among 
contributors. In turn, these could coordinate auditable distribution of 
arising benefits (e.g. royalties, top collaborator prizes, etc) to 
contributors. This is an area of research that FutureLab has been 
pursuing for several years, and we believe is applicable in many arenas 
beyond outbreak research.

Also, a quick note about our COVID Defender project - we're going to 
reposition it from a "yet another contract tracer" to a new category of 
pandemic response management – an infection/proximity risk dosimeter 
with integrated contact tracing, plus "adaptive immuno-certificates". I 
put up a placeholder webpage for the effort here: http://coviddefender.io/

Finally, I wanted to thank the CCG community for all the knowledge, 
expertise and collaboration you've provided over the years. I would be 
happy to include a quote from someone in our community in our press 
release, so let me know if you're amenable.

Moses


PS, if you could share the link on your social feeds, I'd really be 
grateful, thanks!




-- 

*Moses Ma | Managing Partner*

moses.ma@futurelabconsulting.com | moses@futurelab.ventures | 
moses@ngenven.com

v+1.415.568.1068 | skype mosesma | /linktr.ee/moses.tao/ 
<http://linktr.ee/moses.tao>

FutureLab provides strategy, ideation and technology for breakthrough 
innovation and third generation blockchains.

Learn more at /www.futurelabconsulting.com/ 
<http://futurelabconsulting.com>. For calendar invites, please cc: 
mosesma@gmail.com


Or whet your appetite by reading /Agile Innovation/ 
<http://www.amazon.com/Agile-Innovation-Revolutionary-Accelerate-Engagement/dp/B00SSRSZ9A> 
| /Quantum Design Sprint/ 
<https://www.amazon.com/Quantum-Design-Sprint-Application-Disruptive/dp/1799143864> 
| my blog at /psychologytoday.com/ 
<http://www.psychologytoday.com/blog/the-tao-innovation>.

NOTICE TO RECIPIENT: THIS E-MAIL IS MEANT FOR ONLY THE INTENDED 
RECIPIENT OF THE TRANSMISSION. IF YOU RECEIVED THIS E-MAIL IN ERROR, ANY 
REVIEW, USE, DISSEMINATION, DISTRIBUTION, OR COPYING OF THIS E-MAIL IS 
STRICTLY PROHIBITED. PLEASE NOTIFY THE SENDER IMMEDIATELY OF THE ERROR 
BY RETURN E-MAIL AND PLEASE DELETE THIS MESSAGE FROM YOUR SYSTEM. THIS 
EMAIL SHOULD NOT BE CONSIDERED BINDING; HARD COPY DOCUMENTS ARE REQUIRED 
TO CREATE LEGALLY BINDING COMMITMENTS. FOR CALENDAR INVITES, PLEASE CC: 
MOSESMA@GMAIL.COM